Skip to main content

Clinical Trials Using Zirconium Zr 89 Panitumumab

Review the clinical trials studying zirconium zr 89 panitumumab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-2 of 2

An Imaging Agent (89Zr Panitumumab) with PET/CT for Diagnosing Primary Lesions and/or Metastases in Patients with Head and Neck Squamous Cell Carcinoma
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
An Investigational Scan (89Zr-Panitumumab PET/MRI) compared to [18F]FDG-PET/MRI for the Imaging of Head and Neck Squamous Cell Carcinoma in Patients Undergoing Surgery
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama